Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Tasigna Stroke Lawsuit Not Preempted By Federal Law, Judge Rules July 19, 2018 Irvin Jackson Add Your Comments A federal judge has determined that Novartis cannot avoid a Tasigna lawsuit, finding that a case filed by a former user who suffered a stroke should not be dismissed based on pre-emption. However, the Court has barred the plaintiff from pursuing punitive damages in at least one claim. The ruling allows a product liability claim filed by Dennis and Lori McWilliams to proceed, involving allegations that drug maker failed to adequately warn that the side effects of Tasigna may result in constricting and hardening of arteries, which plaintiffs claim caused Dennis McWilliams to suffer a stroke. Tasigna (nilotinib) was approved by the FDA in 2007, and is part of a class of drugs known as kinase inhibitors, which are prescribed for treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) among recently diagnosed adults. It is also approved for the treatment of chronic phase and accelerated phase Ph+ CML in adults who are resistant or intolerant to prior therapy. Learn More About Tasigna Lawsuits Side effects of Tasigna may increase risk of heart attack, stroke, amputation and wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Tasigna Lawsuits Side effects of Tasigna may increase risk of heart attack, stroke, amputation and wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The drug currently carries a black box warning about the risk of QT prolongation, which is a heart rhythm problem that can result in sudden death. However, the Tasigna lawsuits allege that Novartis should have also provided strong warnings about the potential artherosclerosis side effects, which may lead to a stroke, heart attack, amputations or death. The case raises allegations similar to those presented in a number of Tasigna lawsuits being pursued by individuals nationwide, indicating that users and the medical community were not adequately warned about the risk of heart attacks, strokes, the need for amputations and death. The McWilliams and other plaintiffs maintain that Novartis was aware of the Tasigna stroke risk since at least 2010, following reports by clinical investigators who identified side effects in patients that included hardening and narrowing of arteries that supply blood to the legs and arms, heart and brain. In April 2013, Novartis issued a warning to Canadian health professionals and the Canadian public following an investigation by Health Canada; that nations drug regulatory agency. However, no similar notification or warning was provided to doctors and patients in the U.S., the lawsuit claims. Tasigna Case Allowed To Proceed U.S. District Judge Robin Rosenberg, of the Southern District of Florida, issued an order (PDF) on July 9 granting in part and denying in part a motion for summary judgment filed by Novartis. The ruling grants summary judgment denying the McWilliams the ability to pursue punitive damages against Novartis. However, the ruling refused to dismiss the case based on claims of preemption by Novartis. To prove a preemption claim, defendants have to show that state failure-to-warn laws conflict with the drug’s federal approval. To do that, they must show that the FDA would not have approved a change to the label that would have met state law requirements. Judge Rosenberg’s ruling indicates that Novartis failed to prove the FDA would have rejected a stronger label warning had the manufacturer proposed one. However, the ruling sides with Novartis’ claim that the plaintiffs are not entitled to punitive damages, due to New Jersey law, where Novartis is headquartered, which indicates that you cannot award punitive damages when the drug was approved by the FDA. Plaintiffs argued that Florida law, where the plaintiffs are from, should apply instead. On July 13, plaintiffs filed a motion for partial reconsideration (PDF) of the summary judgment, seeking to be allowed to pursue punitive damages. The motion indicates that the Court mistakenly assumed plaintiffs’ arguments did not take New Jersey state laws into consideration. “As argued in Plaintiffs’ opposition brief, Plaintiffs have demonstrated a triable issue of fact on punitive damages under New Jersey law,” the motion states. “Under New Jersey law, punitive damages are available ‘where the product manufacturer knowingly withheld or misrepresented [material and relevant] information required to be submitted under the agency’s regulation.’ Plaintiffs have shown that Novartis not only withheld from the FDA material information related to atherosclerosis-related conditions associated with Tasigna, but that it knowingly made material misrepresentations to the FDA.” The Court has set a trial date for September 17, with a status conference scheduled for August 15. Tags: Amputation, Cancer, Heart Attack, Leukemia, Novartis, Stroke, Tasigna More Tasigna Lawsuit Stories Tasigna Atherosclerosis Risks Concealed from Doctors, Patients in U.S.: Lawsuit June 19, 2023 Tasigna Lawsuit Moves Forward, After Interlocutory Appeal of Preemption Ruling Denied January 10, 2022 Tasigna Side Effects Led To Partial Leg Amputation, Lawsuit Claims November 1, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Tasigna Lawsuit Moves Forward, After Interlocutory Appeal of Preemption Ruling Denied January 10, 2022
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)